Results 181 to 190 of about 86,629 (276)

Carfilzomib-induced sinus bradycardia: A case report and literature review. [PDF]

SAGE Open Med Case Rep
Zhao X, Sun D, Xu R, Qiu Y, Zhao S, Guo C, Chang C, Zhang J.   +7 more
europepmc   +1 more source

Supplement 1. sgRNA sequences targeting PSMC1 to C6 from CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma

, 2023
Chang‐Xin Shi, K. Martin Kortüm, Yuan Xiao Zhu, Laura A. Bruins, Patrick Jedlowski, Patrick G. Votruba, Moulun Luo, Robert A. Stewart, Jonathan M. Ahmann, Esteban Braggio, A. Keith Stewart   +10 more
openalex   +1 more source

Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description [PDF]

, 2019
Blozik, Eva, Eichler, Klaus, Rapold, Ronald, Reich, Oliver, Wieser, Simon   +4 more
core   +1 more source

Azidohomoalanine (AHA) Metabolic Labeling Reveals Unique Proteomic Insights into Protein Synthesis and Degradation in Response to Bortezomib Treatment. [PDF]

Proteomes
Alhourani L, Tabana Y, Anand A, Fahlman RP.   +3 more
europepmc   +1 more source

Clinical analysis of the development of Guillain-Barré syndrome during bortezomib treatment for multiple myeloma. [PDF]

Front Neurol
Li JG, Chen CL, Liu DJ, Zheng ZH, Liu SP, Wang SY, Chen XL.   +6 more
europepmc   +1 more source

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis

, 2010
Wolfgang Lamm, Wolfgang Willenbacher, Alois Lang, Niklas Zojer, Ercan Müldür, Heinz Ludwig, B. Schauer-Stalzer, C C Zielinski, Johannes Drach   +8 more
openalex   +2 more sources

Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation Trial. [PDF]

Cancers (Basel)
Handa S, Koenig K, Zhao Q, Mims AS, Vasu S, Garzon R, Haque T, Benson D, Klisovic RB, Marcucci G, Walker AR, Bhatnagar B.   +11 more
europepmc   +1 more source

Treatment Efficacy and Safety of Bortezomib Combined with Dexamethasone and Lenalidomide Chemotherapy Regimen for Multiple Myeloma

Changyong Yuan, Na Cui, Shumei Liu
openalex   +2 more sources

ACY-1215 and bortezomib cooperatively disrupt NOTCH3 signaling and induce anti-tumor effects in T-ALL models. [PDF]

Biomark Res
Angi E, Ferrarini F, Lanubile A, Montenegro F, Albano M, Mazzucato S, Reggiani F, Amaro AA, Indraccolo S, Minuzzo S.   +9 more
europepmc   +1 more source

A striking response of plasmablastic lymphoma of the oral cavity to bortezomib: a case report [PDF]

, 2015
Makoto Hirosawa, Hiroaki Morimoto, Ryo Shibuya, Shohei Shimajiri, Junichi Tsukada   +4 more
openalex   +1 more source